ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
CRISPR 유전자 편집 시장 규모는 향후 수년간 비약적인 성장을 보일 것으로 예상되며, 2029년에는 CAGR 27.1%로 75억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 유전성 질환의 유병률 증가, 정밀의료에 대한 관심 증가, CRISPR 연구개발에 대한 투자 증가, 노령 인구 증가, 유전자 치료 기술에 대한 관심 증가에 기인합니다. 예측 기간의 주요 동향으로는 유전자 편집 기술의 발전, 연구개발 수의 확대, 약물전달 방법의 혁신, CRISPR 편집 농업의 채택 등이 있습니다.
유전성 질환의 유병률 증가는 향후 수년간 CRISPR 유전자 편집 시장의 성장을 가속할 것으로 예상됩니다. 유전성 질환은 단일 유전자(단유전자성), 다중 유전자(다유전자성) 또는 염색체 이상에 의한 돌연변이로 인해 발생하는 건강 상태입니다. 유전자 돌연변이, 인구 고령화, 근친상간 등의 요인으로 인해 이러한 질병의 발병률이 증가하고 있으며, CRISPR 유전자 편집은 DNA의 정확하고 표적화된 변형을 가능하게 함으로써 유전성 질환의 관리에 중요한 역할을 하고 있습니다. 과학자들은 CRISPR을 사용하여 특정 돌연변이를 식별하고, 수정하고, 정상적인 유전자 기능을 회복하고, 낭포성 섬유증 및 겸상 적혈구 빈혈과 같은 증상을 완화하는 데 사용하고 있습니다. 예를 들어 2022년 7월 미국 비영리단체인 낭포성 섬유증(CF) 재단은 낭포성 섬유증 환자 증가를 보고했으며, 미국에서는 2022년에 약 4만 명의 어린이와 성인이 이 질환에 걸렸으며, 전 세계에서 10만 5,000명 이상이 진단을 받았다고 보고했습니다. 따라서 유전성 질환의 유병률 증가가 CRISPR 유전자 편집 시장의 성장을 가속하고 있습니다.
CRISPR 유전자 편집 시장의 주요 기업은 고객 기반 확대, 매출 증대, 매출 향상을 위해 유전자 치료와 같은 혁신적인 제품 개발에 주력하고 있습니다. 유전자 치료는 유전자를 이용하여 질병이나 장애를 치료, 예방, 치유하는 의료적 접근법입니다. 예를 들어 2023년 12월 미국 식품의약국(FDA)은 겸상적혈구증 치료를 위한 세포 기반 유전자 치료제인 Casgevy를 승인했으며, Casgevy는 CRISPR/Cas9 기술을 사용하여 조혈모세포를 변형시켜 이 유전성 질환에 대한 유망한 치료 옵션을 제공합니다. 제공합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 CRISPR 유전자 편집 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 CRISPR 유전자 편집 시장 : 성장률 분석
세계의 CRISPR 유전자 편집 시장 실적 : 규모와 성장, 2019-2024
세계의 CRISPR 유전자 편집 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 CRISPR 유전자 편집 TAM(Total Addressable Market)
제6장 시장 세분화
세계의 CRISPR 유전자 편집 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
CRISPR 관련 뉴클레아제(Cas 뉴클레아제)
가이드 리보핵산(RNA)
디옥시리보핵산(DNA) 리가아제
제한 엔도뉴클레아제
기타 유형
세계의 CRISPR 유전자 편집 시장 : 서비스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
디자인 툴
플라스미드와 벡터
CRISPR 관련 단백질 9(Cas9)로 가이드 리보핵산(g-RNA)
딜리버리 시스템 제품
기타 서비스
세계의 CRISPR 유전자 편집 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
CRISPR 또는 Cas9
징크 핑거 뉴클레아제
기타 테크놀러지
세계의 CRISPR 유전자 편집 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
농업
바이오메디컬
산업
게놈 공학
질환 모델
기능 유전체학
기타 용도
세계의 CRISPR 유전자 편집 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
학술기관 및 연구 센터
바이오테크놀러지 기업
계약 조사기관(CRO)
제약 및 바이오의약품 기업
세계의 CRISPR 유전자 편집 시장, CRISPR 관련 뉴클레아제(Cas 뉴클레아제)의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Cas9
Cas12
Cas13
기타 Cas 뉴클레아제
세계의 CRISPR 유전자 편집 시장, 가이드 리보핵산(RNA)의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
싱글 가이드 RNA(sgRNA)
듀얼 가이드 RNA
합성 가이드 RNA
세계의 CRISPR 유전자 편집 시장, 디옥시리보핵산(DNA) 리가아제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
T4 DNA 리가아제
대장균 DNA 리가아제
기타 DNA 리가아제
세계의 CRISPR 유전자 편집 시장, 제한 효소의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
II형 제한 효소
I형 및 III형 제한 효소
기타 제한 효소
세계의 CRISPR 유전자 편집 시장, 기타 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
CRISPR 딜리버리 시스템
CRISPR 플라스미드
CRISPR 기반 진단 툴
제7장 지역별·국가별 분석
세계의 CRISPR 유전자 편집 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 CRISPR 유전자 편집 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
CRISPR 유전자 편집 시장 : 경쟁 구도
CRISPR 유전자 편집 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
GenScript Overview, Products and Services, Strategy and Financial Analysis
Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Takara Bio Inc.
OriGene Technologies Inc.
Intellia Therapeutics Inc.
New England Biolabs
Synthego
Arbor Biotechnologies Inc.
Rockland Immunochemicals Inc.
Cellectis
Editas Medicine
Caribou Biosciences Inc.
System Biosciences LLC
Applied StemCell
Addgene
Mirus Bio LLC
Excision BioTherapeutics Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
CRISPR 유전자 편집 시장 2029 : 새로운 기회를 제공하는 국가
CRISPR 유전자 편집 시장 2029 : 새로운 기회를 제공하는 부문
CRISPR 유전자 편집 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁의 전략
제36장 부록
KSA
영문 목차
영문목차
Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing stands as a groundbreaking biotechnological tool that enables precise modifications to the DNA of living organisms. This technology harnesses a natural defense mechanism found in bacteria, where CRISPR sequences in DNA are utilized to identify and cut specific genetic sequences. CRISPR gene editing empowers scientists to add, remove, or alter genetic material with remarkable precision, making it a potent technique for research, therapeutic interventions, and potential treatments for genetic disorders.
The primary types of CRISPR gene editing encompass CRISPR-associated nuclease (Cas nuclease), guide RNA, DNA ligase, restriction endonuclease, and other related components. CRISPR-associated nuclease, commonly known as Cas nuclease, functions as molecular scissors, cleaving targeted DNA sequences as directed by CRISPR. This aspect focuses on the development and utilization of Cas proteins for precise gene editing, offering promising applications across industries such as agriculture, medicine, and biotechnology. It offers diverse services including design tools, plasmids, CRISPR-associated protein 9 (Cas9) and guide RNA (gRNA), delivery systems, and more. Additionally, it encompasses various technologies such as CRISPR/Cas9, zinc finger nucleases, and others, serving applications such as agriculture, biomedical research, industrial processes, genome engineering, disease modeling, functional genomics, and more. These solutions cater to a range of end users including academic institutions, research centers, biotech firms, contract research organizations (CROs), pharmaceutical companies, and biopharmaceutical companies.
The CRISPR gene editing market research report is one of a series of new reports from The Business Research Company that provides CRISPR gene editing market statistics, including the CRISPR gene editing industry global market size, regional shares, competitors with CRISPR gene editing market share, detailed CRISPR gene editing market segments, market trends, and opportunities, and any further data you may need to thrive in the CRISPR gene editing industry. These CRISPR gene editing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The CRISPR gene editing market size has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88 billion in 2025 at a compound annual growth rate (CAGR) of 27.4%. The growth in the historic period can be attributed to increased demand for genome editing technologies, rise in government funding, increased cancer cases, increased prevalence of chronic diseases, increased awareness about CRISPR technology, rise healthcare infrastructure.
The CRISPR gene editing market size is expected to see exponential growth in the next few years. It will grow to $7.51 billion in 2029 at a compound annual growth rate (CAGR) of 27.1%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, growing emphasis on precision medicine, rising investment in CRISPR research and development, increasing geriatric population, growing prominence for the gene therapy procedures. Major trends in the forecast period include advancements in gene editing technology, expansion in the number of research studies, drug discovery and development, innovation in delivery methods, adoption of CRISPR-edited agriculture.
The rising prevalence of genetic disorders is expected to drive the growth of the CRISPR gene editing market in the coming years. Genetic disorders are health conditions caused by abnormalities in the genome, which can result from mutations in a single gene (monogenic), multiple genes (polygenic), or chromosomal abnormalities. The increasing incidence of these disorders is due to factors such as genetic mutations, aging populations, and consanguineous marriages. CRISPR gene editing plays a crucial role in managing genetic disorders by enabling precise and targeted modifications to DNA. Scientists use CRISPR to identify and correct specific mutations, restore normal gene function, and alleviate symptoms in conditions like cystic fibrosis and sickle cell anemia. For example, in July 2022, the Cystic Fibrosis (CF) Foundation, a US-based non-profit organization, reported a rise in cystic fibrosis cases, with nearly 40,000 children and adults in the United States affected in 2022, and over 105,000 people diagnosed worldwide. Therefore, the increasing prevalence of genetic disorders is driving the growth of the CRISPR gene editing market.
Major companies in the CRISPR gene editing market are focusing on developing innovative products, such as gene therapy, to expand their customer base, increase sales, and boost revenue. Gene therapy is a medical approach that uses genes to treat, prevent, or cure diseases and disorders. For example, in December 2023, the US Food and Drug Administration (FDA) approved Casgevy, a cell-based gene therapy for treating sickle cell disease. Casgevy employs CRISPR/Cas9 technology to modify hematopoietic stem cells, offering a promising treatment option for this genetic disorder.
In January 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, entered a four-year research collaboration with Beam Therapeutics. This collaboration focuses on three programs targeting rare genetic diseases affecting the liver, muscles, and central nervous system, leveraging CRISPR gene editing technology. Beam Therapeutics is a US-based biotechnology company specializing in CRISPR gene editing.
Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc., Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited
North America was the largest region in the CRISPR gene editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the CRISPR gene editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The CRISPR gene editing market includes of revenues earned by entities by providing services such as gRNA design and vector construction, cell line and engineering, screening services, drug development services, and gene therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR gene editing market also includes sales of gene editing vectors, laboratory equipment, kits and enzymes, libraries, design tools, antibodies, bioinformatics tools, and cell culture equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
CRISPR Gene Editing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on crispr gene editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for crispr gene editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crispr gene editing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: CRISPR-Associated Nuclease (Cas Nuclease); Guide Ribonucleic Acid (RNA); Deoxyribonucleic Acid (DNA) Ligase; Restriction Endonuclease; Other Types
2) By Services: Design Tools; Plasmid And Vector; CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA); Delivery System Products; Other Services
3) By Technology: CRISPR Or Cas9; Zinc Finger Nucleases; Other Technologies
4) By Application: Agricultural; Biomedical; Industrial; Genome Engineering; Disease Models; Functional Genomics; Other Applications
5) By End User: Academic Institutes And Research Centers; Biotechnology Companies; Contract Research Organizations (CROs); Pharmaceutical And Biopharmaceutical Companies
Subsegments:
1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9; Cas12; Cas13; Other Cas Nucleases
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. CRISPR Gene Editing Market Characteristics
3. CRISPR Gene Editing Market Trends And Strategies
4. CRISPR Gene Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global CRISPR Gene Editing Growth Analysis And Strategic Analysis Framework
5.1. Global CRISPR Gene Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global CRISPR Gene Editing Market Growth Rate Analysis
5.4. Global CRISPR Gene Editing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global CRISPR Gene Editing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global CRISPR Gene Editing Total Addressable Market (TAM)
6. CRISPR Gene Editing Market Segmentation
6.1. Global CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR-Associated Nuclease (Cas Nuclease)
Guide Ribonucleic Acid (RNA)
Deoxyribonucleic Acid (DNA) Ligase
Restriction Endonuclease
Other Types
6.2. Global CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Design Tools
Plasmid And Vector
CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA)
Delivery System Products
Other Services
6.3. Global CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Or Cas9
Zinc Finger Nucleases
Other Technologies
6.4. Global CRISPR Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Agricultural
Biomedical
Industrial
Genome Engineering
Disease Models
Functional Genomics
Other Applications
6.5. Global CRISPR Gene Editing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Academic Institutes And Research Centers
Biotechnology Companies
Contract Research Organizations (CROs)
Pharmaceutical And Biopharmaceutical Companies
6.6. Global CRISPR Gene Editing Market, Sub-Segmentation Of CRISPR-Associated Nuclease (Cas Nuclease), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cas9
Cas12
Cas13
Other Cas Nucleases
6.7. Global CRISPR Gene Editing Market, Sub-Segmentation Of Guide Ribonucleic Acid (RNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-guide RNA (sgRNA)
Dual-guide RNA
Synthetic Guide RNA
6.8. Global CRISPR Gene Editing Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Ligase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
T4 DNA Ligase
E. coli DNA Ligase
Other DNA Ligases
6.9. Global CRISPR Gene Editing Market, Sub-Segmentation Of Restriction Endonuclease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type II Restriction Enzymes
Type I And III Restriction Enzymes
Other Restriction Enzymes
6.10. Global CRISPR Gene Editing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Delivery Systems
CRISPR Plasmids
CRISPR-Based Diagnostic Tools
7. CRISPR Gene Editing Market Regional And Country Analysis
7.1. Global CRISPR Gene Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global CRISPR Gene Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
